MEMBRANE TUMOR-NECROSIS-FACTOR-ALPHA IS INVOLVED IN THE POLYCLONAL B-CELL ACTIVATION-INDUCED BY HIV-INFECTED HUMAN T-CELLS

被引:156
作者
MACCHIA, D
ALMERIGOGNA, F
PARRONCHI, P
RAVINA, A
MAGGI, E
ROMAGNANI, S
机构
[1] UNIV FLORENCE,DIV CLIN IMMUNOL & ALLERGOL,VIALE MORGAGNI 85,I-50134 FLORENCE,ITALY
[2] UNIV PISA,POLICLIN SANTA CHIARA,IST CLIN MED 1,I-56100 PISA,ITALY
关键词
D O I
10.1038/363464a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
INFECTION of CD4+ T cells by human immune deficiency virus-1 (HIV-1) causes severe dysfunction of cellular immunity1-3, but paradoxically results in intense polyclonal activation of B cells, possibly accounting for both hypergammaglobulinaemia and frequent development of B-cell malignancies seen in HIV-infected patients4-7. We have reported that human CD4+ T-cell clones infected with HIV in vitro markedly stimulate immunoglobulin synthesis by B cells through a non-cognate, contact-dependent mechanism8. We show here that HIV-infected T-cell clones do not express the CD40 ligand (CD40L), a molecule critical for non-cognate B-cell activation9, but a small proportion of them do express membrane tumour-necrosis factor (TNF)-alpha. The ability of HIV-infected T-cell clones to induce polyclonal B-cell activation appears to be restricted to TNF-alpha-positive T blasts and is inhibited by antibodies against both TNF-alpha and TNF-alpha receptor. Freshly isolated CD4+ T cells from HIV-infected individuals express TNF-alpha on the cell membrane and induce TNF-alpha-mediated immunoglobulin production by B cells. Thus, membrane TNF-alpha seems to be involved in the polyclonal B-cell activation induced by HIV-infected T cells.
引用
收藏
页码:464 / 466
页数:3
相关论文
共 17 条
[1]   B-CELL ACTIVATION AND HIV-1 INFECTION - DEEDS AND MISDEEDS [J].
AMADORI, A ;
CHIECOBIANCHI, L .
IMMUNOLOGY TODAY, 1990, 11 (10) :374-379
[2]   ACQUIRED IMMUNE DYSFUNCTION IN HOMOSEXUAL MEN - IMMUNOLOGICAL PROFILES [J].
AMMANN, AJ ;
ABRAMS, D ;
CONANT, M ;
CHUDWIN, D ;
COWAN, M ;
VOLBERDING, P ;
LEWIS, B ;
CASAVANT, C .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 27 (03) :315-325
[3]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[4]   IMMUNOPATHOGENESIS OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
BOWEN, DL ;
LANE, HC ;
FAUCI, AS .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (05) :704-709
[5]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362
[6]  
EULER HH, 1985, CLIN EXP IMMUNOL, V59, P267
[7]   QUANTITATIVE CHANGES IN T-HELPER OR T-SUPPRESSOR CYTO-TOXIC LYMPHOCYTE SUBSETS THAT DISTINGUISH ACQUIRED IMMUNE-DEFICIENCY SYNDROME FROM OTHER IMMUNE SUBSET DISORDERS [J].
FAHEY, JL ;
PRINCE, H ;
WEAVER, M ;
GROOPMAN, J ;
VISSCHER, B ;
SCHWARTZ, K ;
DETELS, R .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) :95-100
[8]   A NOVEL ADDITION TO THE T-CELL REPERTORY - CELL-SURFACE EXPRESSION OF TUMOR-NECROSIS-FACTOR CACHECTIN BY ACTIVATED NORMAL HUMAN T-CELLS [J].
KINKHABWALA, M ;
SEHAJPAL, P ;
SKOLNIK, E ;
SMITH, D ;
SHARMA, VK ;
VLASSARA, H ;
CERAMI, A ;
SUTHANTHIRAN, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :941-946
[9]   ASSOCIATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION AND AUTOIMMUNE PHENOMENA [J].
KOPELMAN, RG ;
ZOLLAPAZNER, S .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (01) :82-88
[10]   INTERACTION OF IGE WITH RAT BASOPHILIC LEUKEMIA-CELLS .2. QUANTITATIVE ASPECTS OF BINDING REACTION [J].
KULCZYCK.A ;
METZGER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (06) :1676-1695